UCB
A strategic Team Lead within the New Product Planning (NPP) function driving asset strategy for immunology pipelines. The role involves collaborating with cross-functional partners to translate market and patient insights into long-term value creation scenarios and indicating strategies.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
13% above the average for this role
NEW PRODUCT PLANNING LEAD — NEUROSCIENCE / IMMUNOLOGY - INTERCONTINENTAL HUB
Eli Lilly and Company
New Product Planning Manager
Genesis Molecular AI
Senior Director of New Product Planning
Moderna
Senior Director of New Product Planning
Moderna
Director, New Product Planning
Deciphera Pharmaceuticals
Upstream Marketing Product Manager, Assurance & Monitoring
Solventum